Portage Biotech Inc.
PRTG
$8.10
-$1.01-11.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.77M | -29.78M | -67.28M | -71.08M | -75.34M |
| Total Depreciation and Amortization | 35.00K | 38.00K | 43.00K | 51.00K | 54.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -248.00K | 21.40M | 57.11M | 57.20M | 60.01M |
| Change in Net Operating Assets | 1.52M | 872.00K | 327.00K | 1.30M | 982.00K |
| Cash from Operations | -5.46M | -7.48M | -9.80M | -12.53M | -14.30M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2.81M | 2.81M | 2.81M | 2.81M |
| Cash from Investing | -- | 2.81M | 2.81M | 2.81M | 2.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.00K | -45.00K | -42.00K | -42.00K | -40.00K |
| Issuance of Common Stock | 2.15M | 1.08M | 5.34M | 5.39M | 6.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 8.00K | 8.00K | 7.00K | -12.00K |
| Cash from Financing | 2.10M | 1.04M | 5.31M | 5.35M | 5.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.36M | -3.62M | -1.68M | -4.36M | -5.52M |